Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

May 17, 2017May 17, 2017

New Approach Overcomes Obstacles to Model Vibration-Triggered Raynaud’s

News

An advanced theoretical model of vibration-induced Raynaud’s phenomenon suggests that vibrations cause capillary walls in the hand to thicken, leading to what is known as hand-arm vibration syndrome (HAVS). Although ... Read more

March 22, 2017March 22, 2017

Tracleer, Ventavis Combo May Improve Hand Blood Vessels in Scleroderma with Raynaud’s

News

Tracleer (bosentan) combined with Ventavis (iloprost) reduced abnormalities in the tiny blood vessels in the hands of patients with scleroderma who often experience Raynaud’s phenomenon as a consequence of disrupted ... Read more

February 15, 2017February 15, 2017

Estrogen Likely Contributes to Cold-induced Raynaud’s in Women

News

Estrogen may contribute to the development of Raynaud’s phenomenon in women, according to a study examining the relationship between palm blood flow and the hormone in mice. The findings might ... Read more

December 29, 2016December 29, 2016

Raynaud’s Phenomenon Most Common Symptom Signaling Mixed Connective Tissue Disease

News

Raynaud’s phenomenon may signal the development of mixed connective tissue disease, as a study showed that it was the most common symptom in people who were later diagnosed with the ... Read more

December 2, 2016December 2, 2016

Study Finds Reduced Blood Flow in Heart Tissue of Raynaud’s Patients

News

Patients with both primary and secondary Raynaud’s phenomenon have an abnormally low blood penetration in the heart tissue, which likely explains the increased death rates from heart disease in these ... Read more

November 18, 2016November 18, 2016

Acupressure Fails to Benefit Raynaud’s Patients in Small Study

News

Acupressure does not appear to be an effective way of managing Raynaud’s phenomenon, according to a small clinical trial comparing the intervention to patient education. The trial (NCT01784354) also noted that accurate ... Read more

November 14, 2016November 14, 2016

Artery Block Blood Flow Measurement Tool Useful, But Can’t Discern Raynaud’s Types

News

While measures of the increase in microvessel blood flow after an artery block are abnormal in all types of Raynaud’s disease patients, the method is not sensitive enough to discriminate between ... Read more

October 11, 2016October 11, 2016

Scleroderma Soon After Raynaud’s Could Bring Earlier Internal Organ Problems

News

Internal organ damage from scleroderma tends to occur early in the disease course and simultaneously, rather than in sequences, for patients who develop the disease soon after the onset of Raynaud’s phenomenon, according to a ... Read more

October 4, 2016October 4, 2016

Norepinephrine May Affect Both Raynaud’s and Fibrosis in Scleroderma Patients

News

Norepinephrine signaling, believed to contribute to Raynaud’s phenomenon, also may be driving fibrosis development in patients with scleroderma, according to a study that opens up for new research into the ... Read more

September 29, 2016September 29, 2016

Botox as Effective Treatment for Raynaud’s Not Yet Established, Review Study Finds

News

Sufficient data does not exist to assess if botulinum toxin is effective in treating symptoms of Raynaud’s phenomenon, a review of previously published studies concluded. The report, “Botulinum toxin A in ... Read more